Grenada vs Israel: Incidence of tuberculosis
Incidence of tuberculosis over time
- Grenada
- Israel
How they compare
Israel currently reports 2.4 per 100,000 people against 1.7 per 100,000 people in Grenada, a difference of 0.7 per 100,000 people.
That makes Israel's figure about 1.4 times Grenada's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Israel ahead.
Grenada ranks 198th and Israel ranks 195th of 208 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Grenada | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.97 per 100,000 people | 8.76 per 100,000 people | 6.79 per 100,000 people | Israel |
| 2010s | 2.49 per 100,000 people | 5.01 per 100,000 people | 2.52 per 100,000 people | Israel |
| 2020s | 1.88 per 100,000 people | 2.56 per 100,000 people | 0.676 per 100,000 people | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Grenada or Israel?
- Israel, at 2.4 per 100,000 people against 1.7 per 100,000 people in Grenada as of 2024.
- What is the difference in incidence of tuberculosis between Grenada and Israel?
- 0.7 per 100,000 people, with Israel ahead.
- How many years of comparable data are there for Grenada and Israel?
- 25 years are reported by both, from 2000 to 2024.
- How do Grenada and Israel rank globally for incidence of tuberculosis?
- Grenada ranks 198th and Israel ranks 195th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.